• I am the the stem cell to remodel health and life-span

Welcom Imstem Biotechnology, Inc.

Imstem Biotechnology, Inc. [pronounced as "I am stem (cells)"] is a biotechnology company focusing on developing cell therapeutic product derived from human pluripotent stem cells (hESC or iPSC) for tissue repair, treatment of neural, heart, vascular, blood system diseases and autoimmune diseases. With our state-of-art stem cell technologies, we will be able to provide different kinds of therapeutic and research products with unlimited supply and consistent quality in the near future.

Post Image

Mission

“I am the Stem Cell” to remodel health and life-span.

Post Image

Technology

Stem cell technology offers a wide range of treatments for variety of diseases caused by damage to cells, tissues and organs, stem cell can also regulate the immune system to treat autoimmune disease. Our key proprietary technology is a superior and high efficient method to derive mesenchymal stem cells from hESC (T-MSC), which have strong anti-inflammatory activity to treat autoimmune diseases. T-MSC has better anti-inflammatory efficacy, better consistency compares to traditional adult MSC.

Post Image

Pipelines

IMS001 is a live cell product containing a pure population of mesenchymal stromal/stem cells (MSCs) that are differentiated from pluripotent human embryonic stem cells (hESCs). Indications: Multiple Sclerosis , Inflammatory Bowel Disease

Latest News

Jun '14
05

9/12/2017-ImStem, UConn Obtain U.S..

The U.S. Patent and Trademark Office has issued a patent for human embryonic stem cells derived mesenchymal stem cells, .....

View more
Jun '14
05

6/05/2014-ImStem Biotechnology, In..

Farmington, Conn. - June 5, 2014. ImStem Biotechnology, Inc.(ImStem) announced today it has successfully treated an anim.....

View more
Jun '14
05

9/12/2017-ImStem, UConn Obtain U.S..

The U.S. Patent and Trademark Office has issued a patent for human embryonic stem cells derived mesenchymal stem cells, .....

View More
Jun '14
05

6/05/2014-ImStem Biotechnology, In..

Farmington, Conn. - June 5, 2014. ImStem Biotechnology, Inc.(ImStem) announced today it has successfully treated an anim.....

View More